COMMUNIQUÉS West-GlobeNewswire

Conceivable Life Sciences Strengthens Senior Leadership Team to Support IVI RMA Partnership and U.S. Launch
20/07/2026
Julie O'Shaughnessy named President, Vincent Payet named SVP of Clinical Operations & Partner Success to support AURA's US commercial launch NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Conceivable Life Sciences, the [...]
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
20/07/2026
– Freenome common stock expected to begin trading on the Nasdaq Capital Market under the ticker symbol "FRNM" on July 21, 2026 – – Gross proceeds to Freenome totaled more than $300 million through a PIPE, led by [...]
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
20/07/2026
Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units, and projected to exceed 54,000 annually Products are distributed across [...]
Supreme Court of Canada Upholds Prohibition on Medical Treatment Patents
20/07/2026
MONTREAL, July 20, 2026 (GLOBE NEWSWIRE) -- The Supreme Court of Canada released its highly anticipated decision in Pharmascience Inc. v. Janssen Inc. , which addresses the validity of Janssen’s patent relating to the [...]
Virbac: solid growth of +7.4% at CERS in H1 2026, fueled by double-digit growth of our Supercharge4 platforms
20/07/2026
First half 2026 revenue reached €768m : +7.4% at constant exchange rate and scope (CERS) vs H1 2025 +4.0% at actual rates impacted by currency headwinds Balanced growth in both segments : companion animal +10.0% and [...]
Northwestern Medicine Announces the Robert Havey, MD, Institute for Primary Care
20/07/2026
CHICAGO, July 20, 2026 (GLOBE NEWSWIRE) -- Northwestern Medicine today announced the launch of the Northwestern Medicine Robert Havey, MD, Institute for Primary Care, a transformative new institute dedicated to [...]
A Father's Gift, A World First: Six-Year-Old Becomes First Patient to Receive a Liver Transplant Through a Single Robotic Incision
20/07/2026
RIYADH, Saudi Arabia, July 20, 2026 (GLOBE NEWSWIRE) -- A father's decision to give part of his liver to save his son has resulted in a global medical first. King Faisal Specialist Hospital and Research Centre (KFSH) [...]
Route 92 Medical Celebrates the 200th Patent for its Neurovascular Intervention Portfolio
20/07/2026
New global patents protect Route 92 Medical’s ongoing innovation as the company works to address critical unmet needs in neurovascular treatment WEST JORDAN, Utah, July 20, 2026 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc [...]
New resources on the way for BC farms under pressure from pests and disease
20/07/2026
VANCOUVER, British Columbia, July 20, 2026 (GLOBE NEWSWIRE) -- British Columbia is home to a prolific fruit and vegetable production sector, satisfying local consumers and exporting $1.2 billion in products to markets [...]
Virbac: croissance solide de +7,4 % à PCC au premier semestre 2026, portée par la hausse à deux chiffres de nos plateformes Supercharge⁴
20/07/2026
Au premier semestre 2026, le chiffre d'affaires atteint 768 M€ : +7,4 % à PCC par rapport au premier semestre 2025 +4,0 % à taux réels, impacté par des effets de change défavorables Une croissance équilibrée sur les [...]
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
20/07/2026
Company announcement No. 33 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 29, 2026) Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
La Cour suprême du Canada confirme l’interdiction des brevets sur les traitements médicaux
20/07/2026
MONTRÉAL, 20 juill. 2026 (GLOBE NEWSWIRE) -- La Cour suprême du Canada a rendu sa décision très attendue dans l’affaire Pharmascience Inc. c. Janssen Inc. , qui porte sur la validité du brevet de Janssen relatif au [...]
Novo Nordisk A/S - share repurchase programme
20/07/2026
Bagsværd, Denmark, 20 July 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]
Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market
20/07/2026
Vancouver, Canada, July 20, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (“ Clearmind ”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen - derived treatments for [...]
MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29
20/07/2026
MARIETTA, Ga., July 20, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30 [...]
BrainsWay Announces Strategic Investment in Radial Health, Inc.
20/07/2026
BrainsWay continues to actively evaluate similar investments in leading North American mental health providers to raise awareness and expand access to transformative care BURLINGTON, Mass. and JERUSALEM, July 20, 2026 ( [...]
Xanamem proof-of-concept trial demonstrating anti-depressant activity published in the British Journal of Psychiatry
20/07/2026
Ongoing Xanamem (emestedastat) Alzheimer’s disease pivotal trial progresses toward final results in November this year SYDNEY, July 20, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) today announces that [...]
Positron Secures Multiple PET-CT Orders Amid Accelerating Shift to Cardiac PET
20/07/2026
BUFFALO, NY, July 20, 2026 (GLOBE NEWSWIRE) -- Positron Corporation ("Positron" or the "Company") (OTC: POSC), a leader in advanced molecular imaging technology and comprehensive PET imaging solutions, today announced [...]
Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction
20/07/2026
Highlights combined company’s strong financial position with over $900 million expected at closing, Treeline’s deep clinical-stage pipeline, planned 2027 data updates for TLN-121 and TLN-372, and expected new program [...]

Pages